• Dr Lovorka Đerek and her team evaluated various tests as ANA screening, anti-dsDNA, anti-cardiolipin IgG and IgM, anti-B2GPI IgG and IgM, Anti-tTG IgA and anti-DGP, anti-MPO and anti-PR3.
  • The obtained CVs for each marker met all the internal criteria as well as the ones stated by Sebia
  • They pointed out the user-friendly software, as well as the flexibility of the random access automation.
  • Not having to batch samples, combined with the small footprint of the device is found to be very practical